TSCAN THERAPEUTICS, INC. Public Float
TSCAN THERAPEUTICS, INC. (TCRX) had Public Float of $56.87 million as of 2025-06-30, per its 10-K filed 2026-03-04.
Financial Statements › Notes
dei:EntityPublicFloat · last filed 2026-03-04
- 2025-06-30: Entity Public Float $56.87M.
- 2024-06-30: Entity Public Float $201.65B.
- 2023-06-30: Entity Public Float $74.49M; Entity Public Float as first filed $74.49B.
- 2022-06-30: Entity Public Float $49.20B.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $56.87M 10-K · filed 2026-03-04 | |
| 2024-06-30 | $201.65B 10-K · filed 2025-03-05 | |
| 2023-06-30 | $74.49M 10-K/A · filed 2024-04-10 | $74.49B 10-K · filed 2024-03-06 |
| 2022-06-30 | $49.20B 10-K · filed 2023-03-08 | |
| 2021-06-30 | $0.00 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |